KRON - Kronos Bio GAAP EPS of -$0.59 beats by $0.10 August, 04 2022 05:31 PM Kronos Bio Inc. Kronos Bio press release ( NASDAQ: KRON ): Q2 GAAP EPS of -$0.59 beats by $0.10 . $292.4 million in cash, cash equivalents and investments as of June 30, 2022, providing expected cash runway into Q4 2024 For further details see: Kronos Bio GAAP EPS of -$0.59 beats by $0.10